MAPK3 and breast carcinoma: Our current results suggest that the C‐terminus of PTX3 directly interacts with the N‐terminus of CD44, consequently activating metastasis/invasion and stemness through the involved genes by activating the AKT, ERK1/2 and NF‐κB pathways in breast cancer cells.